Skip to content
Screener

CareDx CDNA Gross margin

Discontinued — last reported Q2 '20

Gross margin at other companies

Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
51.3%-3.0pp
Personalis, Inc. logo
Personalis, Inc.PSNL
13.7%-19.6pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
38.7%-0.1pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
51.9%-1.6pp
NeoGenomics logo
NeoGenomicsNEO
43.9%0.0pp
Quest Diagnostics logo
Quest DiagnosticsDGX
33.1%+0.1pp

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$2.32B+218%
Enterprise value$2.26B+228%
P/S5.6×+3.5×

Profitability

See full
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Calculated from CareDx’s reported figures.

gross profit/total revenue=65.5%

Based on trailing twelve months.

The source filing: CareDx’s 10-Q, filed July 29, 2021. Open the filing →

Filed
Jul 29, 2021, 5:10 PM EDT
Fiscal quarter
Q2 FY2021
Calendar quarter
Q2 2021
Accession
0001217234-21-000190

FAQ

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.